Genetic alterations in SCC include early and late molecular events, with early driver events mainly being RAS and BRAF mutations and RAS mutations associated with papillary carcinoma progression to hypo-fractionated carcinoma (26). This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.